ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/03/05 | 3,285 | 3,330 | 3,160 | 3,215 | -85 | -2.6% | 951,600 |
| 2024/03/04 | 3,335 | 3,405 | 3,290 | 3,300 | +15 | +0.5% | 943,900 |
| 2024/03/01 | 3,495 | 3,530 | 3,265 | 3,285 | -330 | -9.1% | 2,130,000 |
| 2024/02/29 | 3,775 | 3,775 | 3,585 | 3,615 | -155 | -4.1% | 1,091,100 |
| 2024/02/28 | 3,775 | 3,815 | 3,730 | 3,770 | -35 | -0.9% | 992,700 |
| 2024/02/27 | 3,675 | 3,815 | 3,620 | 3,805 | +155 | +4.2% | 1,355,900 |
| 2024/02/26 | 3,680 | 3,735 | 3,605 | 3,650 | +165 | +4.7% | 1,416,500 |
| 2024/02/22 | 3,580 | 3,700 | 3,405 | 3,485 | -130 | -3.6% | 2,212,300 |
| 2024/02/21 | 3,715 | 3,745 | 3,575 | 3,615 | -140 | -3.7% | 1,546,300 |
| 2024/02/20 | 3,725 | 3,865 | 3,655 | 3,755 | +10 | +0.3% | 2,270,600 |
| 2024/02/19 | 3,630 | 3,830 | 3,605 | 3,745 | +145 | +4% | 3,254,500 |
| 2024/02/16 | 3,105 | 3,630 | 3,105 | 3,600 | +565 | +18.6% | 4,906,000 |
| 2024/02/15 | 3,035 | 3,035 | 2,986 | 3,035 | +500 | +19.7% | 1,520,500 |
| 2024/02/14 | 2,565 | 2,572 | 2,506 | 2,535 | -48 | -1.9% | 1,037,400 |
| 2024/02/13 | 2,557 | 2,613 | 2,517 | 2,583 | +34 | +1.3% | 1,147,100 |
| 2024/02/09 | 2,520 | 2,572 | 2,504 | 2,549 | +29 | +1.2% | 762,700 |
| 2024/02/08 | 2,459 | 2,550 | 2,459 | 2,520 | +99 | +4.1% | 1,483,700 |
| 2024/02/07 | 2,595 | 2,598 | 2,328 | 2,421 | -214 | -8.1% | 3,028,900 |
| 2024/02/06 | 2,589 | 2,664 | 2,545 | 2,635 | +53 | +2.1% | 871,000 |
| 2024/02/05 | 2,532 | 2,593 | 2,528 | 2,582 | +24 | +0.9% | 631,600 |
| 2024/02/02 | 2,621 | 2,645 | 2,558 | 2,558 | -61 | -2.3% | 907,700 |
| 2024/02/01 | 2,638 | 2,661 | 2,594 | 2,619 | -42 | -1.6% | 627,900 |
| 2024/01/31 | 2,638 | 2,667 | 2,593 | 2,661 | +7 | +0.3% | 622,900 |
| 2024/01/30 | 2,650 | 2,693 | 2,634 | 2,654 | +25 | +1% | 692,600 |
| 2024/01/29 | 2,738 | 2,741 | 2,609 | 2,629 | -90 | -3.3% | 1,264,300 |
| 2024/01/26 | 2,721 | 2,779 | 2,680 | 2,719 | +7 | +0.3% | 1,269,500 |
| 2024/01/25 | 2,651 | 2,715 | 2,622 | 2,712 | +36 | +1.3% | 918,600 |
| 2024/01/24 | 2,701 | 2,701 | 2,645 | 2,676 | -40 | -1.5% | 984,500 |
| 2024/01/23 | 2,735 | 2,740 | 2,663 | 2,716 | -9 | -0.3% | 1,133,200 |
| 2024/01/22 | 2,784 | 2,784 | 2,661 | 2,725 | -45 | -1.6% | 1,455,800 |
| 2024/01/19 | 2,847 | 2,847 | 2,770 | 2,770 | -52 | -1.8% | 893,900 |
| 2024/01/18 | 2,846 | 2,848 | 2,768 | 2,822 | -48 | -1.7% | 1,058,700 |
| 2024/01/17 | 2,900 | 2,944 | 2,860 | 2,870 | -27 | -0.9% | 907,100 |
| 2024/01/16 | 2,946 | 2,964 | 2,884 | 2,897 | -33 | -1.1% | 788,300 |
| 2024/01/15 | 3,075 | 3,080 | 2,930 | 2,930 | -145 | -4.7% | 1,476,600 |
| 2024/01/12 | 3,090 | 3,095 | 3,010 | 3,075 | +15 | +0.5% | 858,500 |
| 2024/01/11 | 2,966 | 3,085 | 2,966 | 3,060 | +125 | +4.3% | 1,322,800 |
| 2024/01/10 | 2,938 | 2,954 | 2,888 | 2,935 | +7 | +0.2% | 924,100 |
| 2024/01/09 | 2,842 | 3,005 | 2,841 | 2,928 | +132 | +4.7% | 2,321,200 |
| 2024/01/05 | 2,859 | 2,875 | 2,785 | 2,796 | -63 | -2.2% | 875,700 |
| 2024/01/04 | 2,782 | 2,869 | 2,721 | 2,859 | +29 | +1% | 1,341,700 |
| 2023/12/29 | 2,829 | 2,897 | 2,818 | 2,830 | +1 | ±0% | 1,281,300 |
| 2023/12/28 | 2,799 | 2,830 | 2,756 | 2,829 | +51 | +1.8% | 1,492,000 |
| 2023/12/27 | 2,822 | 2,885 | 2,771 | 2,778 | -69 | -2.4% | 1,695,800 |
| 2023/12/26 | 2,852 | 2,907 | 2,820 | 2,847 | +12 | +0.4% | 1,130,700 |
| 2023/12/25 | 2,811 | 2,855 | 2,773 | 2,835 | +28 | +1% | 1,234,400 |
| 2023/12/22 | 2,874 | 2,896 | 2,788 | 2,807 | -43 | -1.5% | 1,563,600 |
| 2023/12/21 | 2,900 | 2,960 | 2,850 | 2,850 | -33 | -1.1% | 1,967,900 |
| 2023/12/20 | 2,894 | 2,939 | 2,827 | 2,883 | +19 | +0.7% | 1,458,600 |
| 2023/12/19 | 2,825 | 2,941 | 2,800 | 2,864 | +38 | +1.3% | 2,519,000 |
301～
350
件表示中 / 3708件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 435,500円 | +21.7% | +999.9% | 0.00% | 18.24倍 | 6.04倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 日本新薬 | 345,000円 | +8.0% | -15.3% | 3.59% | 9.69倍 | 0.94倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 170,000円 | +5.0% | +1.5% | 0.00% | 14.54倍 | 3.87倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| サワイＧＨＤ | 178,300円 | +5.9% | +24.5% | 3.08% | 11.83倍 | 1.11倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| キッセイ薬 | 391,500円 | +3.6% | +6.1% | 3.07% | 13.19倍 | 0.78倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム
